Abstract:Objective: To compare placental findings in women with and without pre-eclampsia. Design: The PURPOSe study included women with stillbirths, women with preterm births and women at term as controls. The placenta of each case was evaluated using the Amsterdam criteria. Setting: Two sites and five tertiary care hospitals of south Asia (Three in India and two in Pakistan). Population: Pregnancies in India and Pakistan with placental histology including women with documented hypertension and documented proteinuria and women with neither hypertension nor proteinuria. Methods: We compared the placental findings of the two groups using the Amsterdam criteria and further evaluated the placental findings in women with and without pre-eclampsia who had a stillbirth, preterm live birth, or term live birth (control). Main outcome measures: The main outcome measures were the frequency of maternal and fetal vascular malperfusion and the frequency of placental inflammation and its components, chorioamnionitis, funisitis, villitis and intervillitis in women with and without pre-eclampsia. Results: A total of 733 women had pre-eclampsia and 2334 women had neither hypertension nor proteinuria. In the placentas of women with pre-eclampsia, 57.3% had maternal vascular malperfusion compared with 37.1% in women without pre-eclampsia (p < 0.0001). There was not a significant difference in the prevalence of fetal vascular hypertension between mothers with (17.1%) and without (14.8%, p = 0.6118) pre-eclampsia. When placentas were classified as 'histologically normal' or not, 61.3% of those from pre-eclamptic pregnancies were classified as abnormal, whereas if there was no pre-eclampsia, only 45.0% were classified as histologically abnormal (p < 0.0001). We also considered rates of placental maternal vascular malperfusion in women with and without pre-eclampsia with stillbirth, preterm neonatal death, and term live birth. In women at term with no pre-eclampsia, 16.7% of the placentas had features of maternal vascular malperfusion. This occurred in 79.9% of women with stillbirths with pre-eclampsia compared with 51.8% of those without pre-eclampsia. Maternal vascular malperfusion was present in 49.7% of preterm live births with pre-eclampsia compared with 33.8% without pre-eclampsia. We also evaluated the inflammatory lesions by whether the mother had or did not have pre-eclampsia. When all inflammatory lesions were considered, women with pre-eclampsia had significantly fewer inflammatory lesions than those women without pre-eclampsia (17.1% versus 23.6% p = 0.001). Each of the specific inflammatory lesions was less common in placentas of women with pre-eclampsia than those with chorioamnionitis (16.1% versus 21.9%, p = 0.004) and funisitis (1.5% versus. 5.1%, p = 0.0004). Conclusions: Of placental lesions in women with pre-eclampsia, maternal vascular malperfusion was the most common. Inflammatory lesions were less common in women with pre-eclampsia.

Placental expression of striatin & endothelial nitric oxide synthase in women with & without pre-eclampsia

Impaired G-Protein Coupled Receptor 30-endothelial NOS signaling axis in pre-eclampsia is mediated by PI3K/Akt down-regulation. Running title: Impaired GPR30-NO signalling axis in pre-eclampsia. Authors:

Expression of Endothelin-1 and Endothelial Nitric Oxide Synthase Gene in Placental Villus in Preeclampsia

The study of endothelial nitric oxide synthase traffic inducer in the placenta of pre-eclampsia

Alterations of maternal serum and placental follistatin-like 3 and myostatin in pre-eclampsia.

Serum and Placental Interleukin-18 Are Elevated in Preeclampsia

The study of endothelial nitric oxide synthase traffic inducer in the umbilical vessels of The Patients with Pre-eclampsia

Endothelial Nitric Oxide Synthase Traffic Inducer in the Umbilical Vessels of the Patients with Pre-Eclampsia

[Nitric oxide and preeclampsia]

Association of a Reduction of G-protein Coupled Receptor 30 Expression and the Pathogenesis of Preeclampsia

Reduced Expression of Follicle Stimulating Hormone Receptor Mrna and Protein in Pregnancies Complicated by Pre-Eclampsia

Declined placental PLAC1 expression is involved in preeclampsia.

Expression of Endothelial Nitric Oxide Synthase Traffic Inducer in the Pladenta of Pregnancy Induced Hypertension

L-arginine-nitric oxide pathway and oxidative stress in plasma and platelets of patients with pre-eclampsia

[Vasohibin and VEGF Protein Levels in Placentae from Pregnancies Complicated by Severe Pre-Eclampsia].

Expressions of survivin protein and survivin mRNA in placenta with pre-eclampsia

Human placenta-based genome-wide mRNA sequencing to identify TEK/IGF1/CSF1/ANGPT2 as crucial segments in the pathogenesis of pre-eclampsia

Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia

Morphological study of the placenta in deliveries with pre-eclampsia: Results from a prospective, observational study in India and Pakistan (PURPOSe)

Placental Expression of Lipoprotein Lipase and Endothelial Lipase in Women with Severe Preeclampsia

Increased expression levels of E-cadherin, cytokeratin 18 and 19 observed in preeclampsia were not correlated with disease severity